Your search returned 26 studies. (Get alerts for new studies):
- Microarray Analysis of Gene Expression and Identification of Progenitor Cells in Lung Carcinoma
Conditions: Carcinoma, Giant Cell - Carcinoma, Non-Small-Cell Lung - Lung Cancer
1 Location available
- Image-Guided Adaptive Conformal Photon Versus Proton Therapy
Conditions: Non-Small-Cell Lung Carcinoma
2 Locations available
- Temsirolimus and Pemetrexed for Recurrent or Refractory Non-Small Cell Lung Cancer
Conditions: Carcinoma, Non-Small-Cell Lung
1 Location available
- Sirolimus and Pemetrexed to Treat Non-Small Cell Lung Cancer
Conditions: Carcinoma, Non-Small-Cell Lung
1 Location available
- An Investigational Drug, PF-02341066, Is Being Studied In Patients With Advanced Non-Small Cell Lung Cancer With A Specific Gene Profile Involving The
Conditions: Carcinoma, Non-Small-Cell Lung
13 Locations available
- DNA Chip Based Prognosis of Lung Cancer
Conditions: Carcinoma, Non-Small-Cell Lung
2 Locations available
- A Study of Erlotinib Plus Radiotherapy (RT) for Patients With Advanced or Inoperable Non-Small-Cell Lung Cancer
Conditions: Carcinoma, Non-small-cell Lung
2 Locations available
- A Study of MM-121 Combination Therapy in Patients With Advanced Non-Small Cell Lung Cancer
Conditions: Carcinoma, Non-Small-Cell Lung
5 Locations available
- Trial of BIBW 2992 (Afatinib) + Cetuximab in Non-Small Cell Lung Cancer
Conditions: Carcinoma, Non-Small-Cell Lung
4 Locations available
- A Study of Pemetrexed & Carboplatin/Cisplatin or Gemcitabine & Carboplatin/Cisplatin With or Without IMC-1121B in Patients Previously Untreate
Conditions: Carcinoma, Non-Small-Cell Lung
51 Locations available
- Stereotactic Body Radiation Therapy (SBRT) in Metastatic Non-small Cell Lung Cancer
Conditions: Non-Small-Cell Lung Carcinoma - Liver Cancer - Adrenal Cancer
2 Locations available
- A Study in Non-Small Cell Lung Cancer
Conditions: Non-Small-Cell Lung Carcinoma
3 Locations available
- AMG 102 and Erlotinib for Advanced Non-Small Cell Lung Cancer
Conditions: Carcinoma, Non-Small-Cell Lung
1 Location available
- Frequency of EGFR Mutations in Latinos/Hispanics With Non-Small Cell Lung Cancer
Conditions: Non-Small-Cell Lung Carcinoma
4 Locations available
- An Efficacy and Safety Study to Assess [18F]-ML-10 in Detecting Response of Tumors to Chemotherapy and Radiation
Conditions: Carcinoma, Non-Small-Cell Lung - Head and Neck Neoplasms
4 Locations available
- Trial of Microdosing Carboplatin
Conditions: Carcinoma, Non-Small-Cell Lung - Urinary Bladder Neoplasms
1 Location available
- Study of ACE-011 to Determine Safe and Effective Dose of ACE-011 for the Treatment of Chemotherapy Induced Anemia in Patients With Advanced Non-small
Conditions: Anemia - Carcinoma, Non-Small-Cell Lung - Carcinoma, Small-Cell Lung - Bladder Cancer - Cancer of Head and Neck - Uterine Cervical Cancer
39 Locations available
- Molecular Profiling and Targeted Therapy for Advanced Non-Small Cell Lung Cancer, Small Cell Lung Cancer, and Thymic Malignancies
Conditions: Carcinoma, Non-Small-Cell Lung - Carcinoma, Small Cell Lung - Carcinoma, Thymic
2 Locations available
- Biodistribution and Safety of the PET Probes [18F]FPRGD2 and [18F]FPPRGD2
Conditions: Breast Cancer - Lung Cancer - Carcinoma, Non-Small-Cell Lung - Cancer of Brain and Nervous System - Glioblastoma
1 Location available
- Molecular Analysis of Thoracic Malignancies
Conditions: Thymus Cancer - Thymoma - Thymic Carcinoma - Lung Cancer - Carcinoma, Non-Small-Cell Lung - Mesothelioma
1 Location available
- Amatuximab for High Mesothelin Cancers
Conditions: Carcinoma, Pancreatic Ductal - Mesothelioma - Ovarian Neoplasms - Carcinoma, Non-Small-Cell Lung
1 Location available
- Ketogenic Diet With Chemoradiation for Lung Cancer (KETOLUNG)
Conditions: Carcinoma, Non-Small-Cell Lung
1 Location available
- Depsipeptide/Flavopiridol Infusion for Cancers of the Lungs, Esophagus, Pleura, Thymus or Mediastinum
Conditions: Carcinoma, Small Cell - Carcinoma, Non-small-cell Lung - Esophageal Neoplasms - Mesothelioma
1 Location available
- A Phase 1/2 Study of the Oral ALK/EGFR Inhibitor AP26113
Conditions: Advanced Malignancies - Carcinoma, Non-Small-Cell Lung - Anaplastic Large Cell Lymphoma - Diffuse Large Cell Lymphoma - Inflammatory Myofibroblastic Tumors
6 Locations available
- KD019 Versus Erlotinib in Subjects With Stage IIIB/IV Non Small Cell Lung Cancer With Progression After First- or Second-Line Chemotherapy
Conditions: Carcinoma, Non-Small-Cell Lung
1 Location available
- Study Assessing Safety, Pharmacokinetics and Efficacy of CC-223 With Either Erlotinib or Oral Azacitidine in Advanced Non-Small Cell Lung Cancer
Conditions: Carcinoma, Non-Small-Cell Lung - Non-Small Cell Lung Cancer
1 Location available
|